New York, NY -- (SBWIRE) -- 04/21/2021 -- The Global Tissue Diagnostic Market is expected to reach USD 5.02 Billion by 2027, according to a new report by Reports and Data. Diagnosis of tissues is the process of extracting and staining tissues for the diagnosis of diseases, particularly cancer. Recently, novel technical developments have been made in network-based medicine, allowing symptoms to be tracked, visualized and controlled more efficiently, resulting in improved management of diseases.

The rising incidence of cancer is a major factor in driving the growth of the industry. The effect of cancer on global society, including the U.S., is huge. Early cancer diagnosis dramatically raises the probability of survival. The key steps responsible for early detection of cancer are to build awareness to promote early diagnosis and screening. It is important for early diagnosis, to recognize possible warning signs of cancer and take rapid steps. Greater awareness of probable symptoms of cancer amongst physicians, nurses, and other healthcare providers, in addition to the general public, would positively impact the survival rate and hence would be instrumental in increasing the tissue diagnostics market demand.

To get a sample PDF copy of the report, visit @ https://www.reportsanddata.com/sample-enquiry-form/3411

The market in the Asia Pacific region is expected to grow at the fastest rate of 7.3% in the forecast period. The high growth of the APAC region is owing to the growing prevalence of target conditions, growth of the pharmaceutical industry, and a surge in R&D activities the diagnostic procedures, among others.

In May 2020, Agilent Technologies Inc. Visiopharm announced the signing of a co-agreement for end-to-end standardization and quality of tissue diagnostics and cater to the growing requirements of pathology labs globally.

Key participants include

· Thermo Fisher Scientific

· Danaher

· Becton, Dickinson, and Company

· Agilent Technologies

· Abbott

· Roche

· Merck KGaA

· Biogenex, Hologic Inc.

· Abcam

For the purpose of this report, Reports and Data has segmented the Global Tissue Diagnostics Market on the basis of type, technology, application, end-user, and region:

Type Outlook (Revenue, USD Million; 2017-2027)

· Diagnostic Kits

· Antibodies

· Slide Training System

· Tissue Processing System

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3411

Technology Outlook (Revenue, USD Million; 2017-2027)

· Immunohistochemistry

· In Situ Hybridization

· Digital Pathology & Workflow

· Primary & Special Training

· Anatomic Pathology

Application Outlook (Revenue, USD Million; 2017-2027)

· Breast Cancer

· Lymphoma

· Prostate Cancer

· Non-Small Lung Cancer

· Others

End-User Outlook (Revenue, USD Million; 2017-2027)

· Hospitals

· Research Laboratories

· Pharmaceutical Organizations

· Contract Research Organizations

Regional Outlook (Revenue, USD Million; 2017-2027)

· North America

· Europe

· Asia Pacific

· Latin America

· Middle East & Africa

To know more about the report, visit @ https://www.reportsanddata.com/report-detail/tissue-diagnostics-market

Report Highlights:

Sales & Revenue Analysis – The report includes accurate market sales volume and revenue estimations, assessed using useful analytical tools.

Supply and Value Chain Analysis: This section of the report offers a detailed examination of the global supply and value chains, which have been drastically affected by the COVID-19 pandemic.

Competitive Scenario: This section highlights both the emerging and dominant players of the global Tissue Diagnostics market and summarizes their company profiles, product portfolios, production capacities, and cost and revenue analyses.

Thank you for reading our report. In case of further queries regarding the report or inquiry about its customization, please connect with us. We will ensure your report is well-suited to your requirements.

Contact Us:
John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com